Prolactin level is significantly elevated in lesional skin of patients with psoriasis

International Journal of Dermatology

Volumn 50, Issue 6, 2011, Pages 693-696

  El Khateeb, Ekramy A ^a   Zuel Fakkar, Nehal M ^a   Eid, Safaa M ^b   Abdul Wahab, Soha E ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ADULT; ARTICLE; BLISTER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; PATHOGENESIS; PROLACTIN BLOOD LEVEL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SCORING SYSTEM; TISSUE LEVEL;

ADULT; BLISTER; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PROLACTIN; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN; YOUNG ADULT;

EID: 79956219036     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04752.x     Document Type: Article

References (23)

1. Krueger G, Ellis CN. Psoriasis - recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005; 53(Suppl): 94-100.
2. Damasiewicz-Bodzek A, Kos-Kudła B. [Hormonal factors in etiopathogenesis of psoriasis]. Pol Merkur Lekarski 2007; 22: 75-78.
3. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the "brain-skin connection". Trends Immunol 2006; 27: 32-39.
4. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996; 17: 639-669.
5. Foitzik K, Langan EA, Paus R. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 2009; 129: 1071-1087.
6. Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999; 135: 1104-1110.
7. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-1631.
8. Weber G, Neidhardt M, Frey H, et al. Treatment of psoriasis with bromocriptin. Arch Dermatol Res 1981; 271: 437-439.
9. Valentino A, Fimiani M, Bilenchi R, et al. Therapy with bromocriptine and behavior of various hormones in psoriasis patients. Boll Soc Ital Biol Sper 1984; 60: 1841-1844.
10. Sánchez Regaña M, Umbert Millet P. Psoriasis in association with prolactinoma: three cases. Br J Dermatol 2000; 143: 864-867.
11. Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992; 6: 1023-1031.
12. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996; 59: 599-614.
13. Matera L, Mori M. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and Tcells. Ann N Y Acad Sci 2000; 917: 505-513.
14. Kanda N, Watanabe S. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 2007; 148: 2317-2325.
15. Girolomoni G, Phillips JT, Bergstresser PR. Prolactin stimulates proliferation of cultured human keratinocytes. J Invest Dermatol 1993; 101: 275-279.
16. de la Torre NG, Turner HE, Wass JA. Angiogenesis in prolactinomas: regulation and relationship with tumor behavior. Pituitary 2005; 8: 17-23.
17. Kanda N, Shibata S, Tada Y, et al. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 2009; 39: 996-1006.
18. De Bellis A, Bizzarro A, Pivonello R, et al. Prolactin and autoimmunity. Pituitary 2005; 8: 25-30.
19. Matera L, Galetto A, Geuna M, et al. Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology 2000; 100: 29-36.
20. Giasuddin AS, El-Sherif AI, El-Ojali SI. Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 1998; 197: 119-122.
21. Gorpelioglu C, Gungor E, Alli N. Is prolactin involved in etiopathogenesis of psoriasis? J Eur Acad Dermatol Venereol 2008; 22: 1135-1136.
22. Fredriksson T, Pattersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
23. Kool J, Reubsaet L, Wesseldijk F, et al. Suction blister fluid as potential body fluid for biomarker proteins. Proteomics 2007; 20: 3638-3650.